DocPharm Posted - 23 hours ago

@NoBSPls have to get $Roiv on board ….if they say yes, then it’s done

DocPharm Posted - 1 day ago

@INTL interesting I thought of $roiv $ Genevant too That would make a crazy bidding war…would it be allowed with the pending litigation? Given, the open lawsuits for an identical or nearly identical LNP granted to them by Genevant/arbutus on a few occasions Just my 2 Pennie’s

DocPharm Posted - 3 days ago

$ABUS titles next week ladies and gents They are going to be straight bangers … $ROIV should get a pop from it too 😏

jaydilks Posted - 4 days ago

$GRPM I have this odd feeling that $CELH is going to double or triple and be a frequent leader in the GRPM ETF. It was chosen because its Growth at A Reasonable Price. Here are the other leaders today. $ROIV $VAL

DocPharm Posted - 4 days ago

$GRTS interested to see who the buying party is - $MRNA One would think it could be a loophole into LNP, since they have existing contacts with transfer of ownership - with $ABUS & $ROIV And it would compliment their current portfolio

ManosDeDiamante07 Posted - 4 days ago

$ROIV

Carl_K Posted - 4 days ago

$IPA, $RXRX $ABSI $ROIV mentioned for comparison.

DocPharm Posted - 5 days ago

$XBI rebound time soon Artificially held under 100 for funds to get resettled Bios to follow $ABUS $ROIV $RHHBY

DocPharm Posted - 6 days ago

$ABUS load it while you can, on dips, before next data nugget… likely to run oversold or pop on notification for AALSD then run negative Mike and Mike, what to make of the cofounder conundrum… Mike Sofia, cofounder, retiring No new CEO named for also cofounder interim Mike M. Who is being tapped in or re-tapped ? $ROIV

DocPharm Posted - 1 week ago

$ABUS less than 90 days to co-founder Michael Sofia’s retirement 0 insider shares sold 🕰️ $ROIV

DocPharm Posted - 1 week ago

$PFE let the ascent begin Biotech should be rotating in here again $ABUS $ROIV $RHHBY

MisagalCapital Posted - 1 week ago

$ROIV – A Biopharma Powerhouse! 🚀 With key drugs like Batoclimab & Brepocitinib targeting autoimmune diseases and Mosliciguat focusing on pulmonary hypertension linked to lung disease (PH-ILD), Roivant is tackling huge unmet medical needs. The $5.2B cash boost from Telavant’s sale and their upcoming Q4 catalysts set them up for major growth. Considering their $1.5B share buyback catalyst, and I believe this stock is a hidden gem! Trading around $11, it got a multibagger potential. 🌟 #Biotech #LungDisease #GrowthStocks #ROIV #UndervaluedGems #PHILD

DocPharm Posted - 1 week ago

$ABUS $ROIV $PFE $RHHBY looks like funds are cycling back into the tickers

DocPharm Posted - 1 week ago

$ROIV $TLIS

S_Franconi Posted - 09/30/24

$ROIV @G101SPM G Can you run this one please?

TimingTimingTiming Posted - 09/30/24

$ROIV Why is this under $20 ?

renoH4 Posted - 09/30/24

$ROIV it is time to pay a special dividend

Beach27 Posted - 09/26/24

$ROIV This does not look good, basically using the 6 billion to buy the shares of all the BOD’s and original investors. They could never sell,without the 6 billion, stock would drop to zero. Anytime they have a product to sell, they get ride of it. Just a money machine for everyone, but retail investors. This program could run forever. At some point, you think someone asking questions to Peter. “When will you get the price of your stock to $20” So your retail investors can get a return, not just the fat cats.

insiderbuyingselling Posted - 09/26/24

$ROIV new insider selling: 926000 shares. http://insiderbuyingselling.com/?t=ROIV

DocPharm Posted - 09/26/24

$ROIV I wonder if Kriya will IPO soon…I know $TLIS settled on some money they owe them, earlier this month Viveks brother runs the show and Keith Manchester is involved with QVT

DocPharm Posted - 09/26/24

$ABUS Done ✅with the excess to $ROIV 1/2 position still stays with $AMZN

Shortsales Posted - 09/26/24

$ABUS $ROIV

malky2945 Posted - 09/26/24

$PFE bought Arena for 6.7 billion, just for it's questionable UC drug Velsipity, while donating UC drug TL1A for $ROIV who sold it for 7 billion for $RHHBY after spending just a 15 million on phase III. If you don't have 15 million to finish developing your in-house drug, how do you spend 6.7 billion buying other unproven company's? Still

ShareholderIncentives Posted - 09/26/24

$ROIV $ABUS Yay! Yesterday Roivant insiders dumped more large chunks of shares. While not quite as relentless as Moderna, they’re pretty bad. It’s disgusting. No wonder the stock continues to be soft. Only time will tell if they stop. Meanwhile, Arbutus insiders just sit on their hands despite holding vested Options and RSUs. They must be one of the following: (a) insane; (b) sane but outliers, (c) prohibited from selling due to timing/inside information, or (d) truly believe their patience will be rewarded.

DocPharm Posted - 09/25/24

$ABUS $ROIV Anyone happen to know the outcome of the oral proceedings with the EPO scheduled for June 6, 2024 VS $MRK & $MRNA

insiderbuyingselling Posted - 09/24/24

$ROIV new insider selling: 1983257 shares. http://insiderbuyingselling.com/?t=ROIV

DocPharm Posted - 09/24/24

$ROIV phenomenal volume continued for months … IMO, massive move incoming in a few days - weeks ✅mark it

DocPharm Posted - 09/24/24

$ABUS $ROIV pre-planned 100% They are currently doing a buyback If it wasn’t pre planned, it would be in essence propping the bid for himself & insider trading